186 related articles for article (PubMed ID: 25650807)
1. Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.
Fernandez-Cuesta L; Sun R; Menon R; George J; Lorenz S; Meza-Zepeda LA; Peifer M; Plenker D; Heuckmann JM; Leenders F; Zander T; Dahmen I; Koker M; Schöttle J; Ullrich RT; Altmüller J; Becker C; Nürnberg P; Seidel H; Böhm D; Göke F; Ansén S; Russell PA; Wright GM; Wainer Z; Solomon B; Petersen I; Clement JH; Sänger J; Brustugun OT; Helland Å; Solberg S; Lund-Iversen M; Buettner R; Wolf J; Brambilla E; Vingron M; Perner S; Haas SA; Thomas RK
Genome Biol; 2015 Jan; 16(1):7. PubMed ID: 25650807
[TBL] [Abstract][Full Text] [Related]
2. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.
Ju YS; Lee WC; Shin JY; Lee S; Bleazard T; Won JK; Kim YT; Kim JI; Kang JH; Seo JS
Genome Res; 2012 Mar; 22(3):436-45. PubMed ID: 22194472
[TBL] [Abstract][Full Text] [Related]
3. Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma.
Jiang L; Chen S; Stinnett V; Haley L; Morsberger L; Shane A; Hardy M; Smith K; Gocke CD; Lin MT; Zou YS
Cancer Genet; 2021 Nov; 258-259():18-22. PubMed ID: 34233240
[TBL] [Abstract][Full Text] [Related]
4. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
Moskalev EA; Frohnauer J; Merkelbach-Bruse S; Schildhaus HU; Dimmler A; Schubert T; Boltze C; König H; Fuchs F; Sirbu H; Rieker RJ; Agaimy A; Hartmann A; Haller F
Lung Cancer; 2014 Jun; 84(3):215-21. PubMed ID: 24674157
[TBL] [Abstract][Full Text] [Related]
5. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
[TBL] [Abstract][Full Text] [Related]
6. Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC.
Li W; Liu Y; Li W; Chen L; Ying J
J Thorac Oncol; 2020 Jul; 15(7):1223-1231. PubMed ID: 32151779
[TBL] [Abstract][Full Text] [Related]
7. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
Takeuchi K; Choi YL; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Takada S; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H
Clin Cancer Res; 2008 Oct; 14(20):6618-24. PubMed ID: 18927303
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers.
Xia P; Zhang L; Li P; Liu E; Li W; Zhang J; Li H; Su X; Jiang G
J Transl Med; 2021 Jul; 19(1):308. PubMed ID: 34271921
[TBL] [Abstract][Full Text] [Related]
9. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
Vollbrecht C; Lenze D; Hummel M; Lehmann A; Moebs M; Frost N; Jurmeister P; Schweizer L; Kellner U; Dietel M; von Laffert M
BMC Cancer; 2018 Nov; 18(1):1158. PubMed ID: 30466405
[TBL] [Abstract][Full Text] [Related]
10. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
[TBL] [Abstract][Full Text] [Related]
11. Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomas.
Rathe SK; Popescu FE; Johnson JE; Watson AL; Marko TA; Moriarity BS; Ohlfest JR; Largaespada DA
Sci Rep; 2019 Jan; 9(1):358. PubMed ID: 30674975
[TBL] [Abstract][Full Text] [Related]
12. Novel fusion genes and chimeric transcripts in ependymal tumors.
Olsen TK; Panagopoulos I; Gorunova L; Micci F; Andersen K; Kilen Andersen H; Meling TR; Due-Tønnessen B; Scheie D; Heim S; Brandal P
Genes Chromosomes Cancer; 2016 Dec; 55(12):944-953. PubMed ID: 27401149
[TBL] [Abstract][Full Text] [Related]
13. Massive NGS data analysis reveals hundreds of potential novel gene fusions in human cell lines.
Gioiosa S; Bolis M; Flati T; Massini A; Garattini E; Chillemi G; Fratelli M; Castrignanò T
Gigascience; 2018 Oct; 7(10):. PubMed ID: 29860514
[TBL] [Abstract][Full Text] [Related]
14. Overview of Fusion Detection Strategies Using Next-Generation Sequencing.
Schröder J; Kumar A; Wong SQ
Methods Mol Biol; 2019; 1908():125-138. PubMed ID: 30649725
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer.
Lira ME; Kim TM; Huang D; Deng S; Koh Y; Jang B; Go H; Lee SH; Chung DH; Kim WH; Schoenmakers EF; Choi YL; Park K; Ahn JS; Sun JM; Ahn MJ; Kim DW; Mao M
J Mol Diagn; 2013 Jan; 15(1):51-61. PubMed ID: 23246132
[TBL] [Abstract][Full Text] [Related]
16. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
[TBL] [Abstract][Full Text] [Related]
17. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.
Li W; Zhang J; Guo L; Chuai S; Shan L; Ying J
J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
[TBL] [Abstract][Full Text] [Related]
18. Regional perturbation of gene transcription is associated with intrachromosomal rearrangements and gene fusion transcripts in high grade ovarian cancer.
Krzyzanowski PM; Sircoulomb F; Yousif F; Normand J; La Rose J; E Francis K; Suarez F; Beck T; McPherson JD; Stein LD; Rottapel RK
Sci Rep; 2019 Mar; 9(1):3590. PubMed ID: 30837567
[TBL] [Abstract][Full Text] [Related]
19. ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data.
Li Y; Heavican TB; Vellichirammal NN; Iqbal J; Guda C
Nucleic Acids Res; 2017 Jul; 45(13):e120. PubMed ID: 28472320
[TBL] [Abstract][Full Text] [Related]
20. nFuse: discovery of complex genomic rearrangements in cancer using high-throughput sequencing.
McPherson A; Wu C; Wyatt AW; Shah S; Collins C; Sahinalp SC
Genome Res; 2012 Nov; 22(11):2250-61. PubMed ID: 22745232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
